Senate Passes Energy Permitting Bill 62-33 and Makes Data Centers Pay for Their Power

Image
Photo: blickpixel / Pixabay November 21, 2026 · Energy The Senate passed a bipartisan bill on Thursday, November 19, to speed up federal permits for power plants, transmission lines and pipelines. The vote was 62–33. The bill also requires data centers to pay for the energy they use. It is the first major action by Congress since the midterm elections, and it now goes to the House. What the bill does Faster reviews: it shortens the timeline to start large energy projects. Environmental reviews under current law often take five years or more. Data centers: it is written to make sure data centers cover their own energy costs. Anger over rising electricity bills was a major issue in the elections. Law changes: it revises the National Environmental Policy Act, the Clean Water Act and the Endangered Species Act, and limits court challenges to approved projects. Name: the Bipartisan American Affordability and Jobs Act of 2026. The vote For: 62 senators, incl...

US Lifts Export Controls on Anthropic's Claude Fable 5 & Mythos 5: Global Access Restored and New AI Drug Discovery Initiative

Major news has shaken the artificial intelligence industry. The US Commerce Department under the Trump administration has officially lifted export controls on Anthropic’s most advanced AI models: Claude Fable 5 and Mythos 5.

This pivotal regulatory shift reopens doors for global users and marks a new era in Anthropic's market expansion. Here is a detailed breakdown of what this means for the AI ecosystem and Anthropic's surprising new venture into healthcare.

1. Export Restrictions Lifted for Claude Fable 5 & Mythos 5

In mid-June, Anthropic temporarily disabled access to its cutting-edge Fable 5 and Mythos 5 models to comply with strict national security restrictions imposed by the US government. The pause left many international developers and premium subscribers eagerly awaiting their return.

With the US Commerce Department clearing these restrictions, Anthropic is rapidly restoring services:

  • Claude Fable 5: Available to global users on the Claude platform starting today. International clients can once again leverage its high-tier capabilities.

  • Mythos 5: Access has been restored for select US organizations. Anthropic is actively working alongside the US government to safely expand deployment to more domestic and international partners.

2. Easing Regulations Amid Tightening Global AI Competition

The decision to lift these export controls comes at a time of fierce global competition. Observers note that the rise of powerful international AI models—particularly from China—fostered fears that over-regulating domestic tech giants could cause the US to lose its technological edge.

By strategically relaxing boundaries, the US government aims to ensure American AI companies like Anthropic remain highly competitive on the global stage, allowing them to capture market share without being hindered by prolonged administrative delays.

3. Anthropic's New Frontier: Launching an Internal AI Drug Discovery Program

In tandem with the regulatory green light, Anthropic announced a massive diversification of its business model. The company is officially venturing into biotech by launching an internal drug discovery program.

Led by Anthropic's Head of Life Sciences, the initiative will leverage custom AI tools to discover treatments for what the industry classifies as "neglected diseases." These are underserved conditions that traditional pharmaceutical companies often overlook due to high development costs or lower profit margins.

A spokesperson confirmed to CNBC that while the endeavor is in its earliest stages, the company plans to share data-driven milestones as their research progresses.

Conclusion: A Dual Catalyst for Growth

The simultaneous lifting of export controls and the launch of a dedicated life sciences initiative mark a monumental milestone for Anthropic. By regaining global access for Claude Fable 5 and entering the vital arena of AI-driven medical research, Anthropic is positioning itself not just as a software provider, but as a crucial infrastructure player solving complex real-world challenges.

Comments

Popular posts from this blog

Why European Oil Companies Are Outperforming America’s: The Secret World of Energy Trading

Inside Anthropic’s Slack Takeover: What 'Claude Tag' Means for Enterprise AI

Buying the Dip: Jim Cramer’s Top Stock Picks Amid Market Rotation